Get the Stockscreener App
32.90
3.75%
1.19
Atricure Inc stock is traded at $32.90, with a volume of 483.45K.
It is up +3.75% in the last 24 hours and down -7.04% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$31.71
Open:
$31.44
24h Volume:
483.45K
Relative Volume:
1.06
Market Cap:
$1.64B
Revenue:
$499.95M
Net Income/Loss:
$-36.36M
P/E Ratio:
-42.73
EPS:
-0.77
Net Cash Flow:
$24.22M
1W Performance:
+2.65%
1M Performance:
-7.04%
6M Performance:
+2.02%
1Y Performance:
-6.83%
1-Day Range:
$31.12
$32.95
1-Week Range:
$31.12
$34.38
52-Week Range:
$28.29
$43.11
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
32.90 | 1.58B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
How rising interest rates impact AtriCure Inc. stockTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Can AtriCure Inc. stock beat market expectations this quarterJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Exit strategy if you’re trapped in AtriCure Inc.Trade Analysis Report & Proven Capital Preservation Methods - newser.com
Why AtriCure Inc. stock attracts high net worth investors2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Why AtriCure Inc. stock remains undervaluedSell Signal & Capital Efficiency Focused Ideas - newser.com
How AtriCure Inc. stock reacts to Fed rate cutsJuly 2025 WrapUp & Smart Allocation Stock Reports - Fundação Cultural do Pará
AtriCure Inc. stock trendline breakdownSell Signal & AI Enhanced Trade Execution Alerts - newser.com
What’s the recovery path for long term holders of AtriCure Inc.Earnings Summary Report & Community Trade Idea Sharing - newser.com
Why AtriCure Inc. stock could benefit from AI revolutionTreasury Yields & AI Forecast for Swing Trade Picks - Fundação Cultural do Pará
Is AtriCure Inc. stock near bottom after decline2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
What drives AtriCure Inc stock priceSwing Trading Watchlist & Free Daily Investment Newsletter Subscription - earlytimes.in
AtriCure at Stifel 2025 Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Is AtriCure Inc. stock trading near support levelsRecession Risk & Long-Term Capital Growth Strategies - newser.com
Why AtriCure Inc. stock is recommended by analystsBreakout Watch & Step-by-Step Swing Trade Plans - newser.com
Transcript : AtriCure, Inc. Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 02 - MarketScreener
AtriCure at UBS Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
AtriCure (ATRC) Is Down 5.8% After Raising Revenue Guidance and Narrowing Net Loss – Has The Bull Case Changed? - simplywall.st
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):